Lin Fen, Liang Jian-Lian, Guan Ze-Xiang, Wu Min, Yang Li-Ye
Precision Medical Lab Center, Chaozhou Central Hospital, Chaozhou, Guangdong Province, P. R. China.
Precision Medical Lab Center, People's Hospital of Yangjiang, No.42 Dongshan Road, Jiangcheng District, Yangjiang, Guangdong Province, 529500, P. R. China.
BMC Pediatr. 2024 Dec 20;24(1):828. doi: 10.1186/s12887-024-05285-x.
Since the outbreak of COVID-19 in late 2019, the transmission dynamics and clinical presentation patterns of influenza A (Flu A) virus have undergone changes.
This article conducted a comparative analysis in clinical characteristics and laboratory results of pediatric patients with Flu A before, during, and after the COVID-19 pandemic.
The medical records of 885 children hospitalized with Flu A virus infection at a tertiary hospital in Guangdong Province, China, were retrospectively analyzed. Flu A was confirmed in these cases using a direct immunofluorescence antigen assay. The clinical data for this study span from January 1, 2018, to May 31, 2023.
In our study, we observed a total of 340 cases before the COVID-19 pandemic, 196 cases during the pandemic, and 349 cases after the pandemic. Patients after the pandemic had a higher median age on admission (5.66 years, range 3.41-7.70) and exhibited more respiratory symptoms such as cough, sore throat, and nasal stuffiness. The length of hospital stay was longer, and there was a higher percentage of patients with fever duration ≥ 5 days among Flu A patients during the pandemic. Compared to before and during the COVID-19 pandemic, Flu A patients after the pandemic showed significantly reduced white blood cell (WBC) and platelet (PLT) counts (P < 0.001), along with elevated levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in laboratory indexes (P < 0.001). Furthermore, more hospitalized children after the pandemic were diagnosed with benign acute childhood myositis (BACM).
Our research results indicates a significant decrease in Flu A cases during the COVID-19 pandemic, and hospitalized children with Flu A have more severe clinical symptoms after the COVID-19 pandemic. These findings have implications for public health policy and clinical management of Flu A cases.
Not applicable.
自2019年末新型冠状病毒肺炎(COVID-19)疫情爆发以来,甲型流感(Flu A)病毒的传播动态和临床表现模式发生了变化。
本文对COVID-19大流行之前、期间和之后甲型流感儿科患者的临床特征和实验室检查结果进行了比较分析。
回顾性分析了中国广东省一家三级医院收治的885例甲型流感病毒感染住院儿童的病历。采用直接免疫荧光抗原检测法确诊这些病例为甲型流感。本研究的临床数据涵盖2018年1月1日至2023年5月31日。
在我们的研究中,共观察到COVID-19大流行之前340例、大流行期间196例和大流行之后349例。大流行之后的患者入院时中位年龄较高(5.66岁,范围3.41 - 7.70岁),表现出更多呼吸道症状,如咳嗽、咽痛和鼻塞。住院时间更长,且大流行期间甲型流感患者中发热持续时间≥5天的患者比例更高。与COVID-19大流行之前和期间相比,大流行之后的甲型流感患者白细胞(WBC)和血小板(PLT)计数显著降低(P < 0.001),实验室指标中丙氨酸氨基转移酶(ALT)和天冬氨酸氨基转移酶(AST)水平升高(P < 0.001)。此外,大流行之后更多住院儿童被诊断为良性急性儿童肌炎(BACM)。
我们的研究结果表明,COVID-19大流行期间甲型流感病例显著减少,且COVID-19大流行之后甲型流感住院儿童临床症状更严重。这些发现对甲型流感病例的公共卫生政策和临床管理具有启示意义。
不适用。